Sofinnova News http://209.237.161.91 Sofinnova News en Copyright 2008 Mon, 12 Jul 2010 00:00:00 +0800 http://www.php.net/ http://blogs.law.harvard.edu/tech/rss <![CDATA[THE REMEDY: Amarin's Lessons In Crisis Management]]> Source: Dow Jones Investment Banker

LONDON (Dow Jones Investment Banker)--If you're running a biotech company and your lead drug has just failed in late-stage clinical trials, should you seek more funds and a new focus or just fold the business and hand remaining cash back to investors?

Such was the question facing Dr. Declan Doogan, now Amarin Corp's interim CEO, who within weeks of joining the company as head of R&D in April 2007 saw the drug Miraxion fail in Huntington's disease. Three years on, his company having ... ]]> http://209.237.161.91/news_detail.php?id=293 http://209.237.161.91/news_detail.php?id=293 Mon, 12 Jul 2010 00:00:00 +0800 <![CDATA[Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma]]> http://209.237.161.91/uploads/news292.pdf http://209.237.161.91/uploads/news292.pdf Thu, 08 Jul 2010 00:00:00 +0800 <![CDATA[Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders]]> http://www.vicepttx.com/pdf/Vicept%20Release%20Completes%20Series%20A%206.30.10.pdf

]]> http://www.vicepttx.com/pdf/Vicept%20Release%20Completes%20Series%20A%206.30.10.pdf http://www.vicepttx.com/pdf/Vicept%20Release%20Completes%20Series%20A%206.30.10.pdf Wed, 30 Jun 2010 00:00:00 +0800 <![CDATA[Anthera Enrolls First Patients in Pivotal Varespladib Phase 3 Clinical Study]]> http://investor.anthera.com/releasedetail.cfm?ReleaseID=482003

]]> http://investor.anthera.com/releasedetail.cfm?ReleaseID=482003 http://investor.anthera.com/releasedetail.cfm?ReleaseID=482003 Wed, 23 Jun 2010 00:00:00 +0800 <![CDATA[KXEN Secures $8 Million in Series D Funding]]> http://www.kxen.com/index.php?option=com_content&task=view&id=637&Itemid=1026

]]> http://www.kxen.com/index.php?option=com_content&task=view&id=637&Itemid=1026 http://www.kxen.com/index.php?option=com_content&task=view&id=637&Itemid=1026 Wed, 16 Jun 2010 00:00:00 +0800